{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T08:22:25Z","timestamp":1746346945911},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2003,12,1]],"date-time":"2003-12-01T00:00:00Z","timestamp":1070236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2003,12]]},"DOI":"10.1016\/j.brainres.2003.08.051","type":"journal-article","created":{"date-parts":[[2003,10,9]],"date-time":"2003-10-09T02:10:47Z","timestamp":1065665447000},"page":"246-251","source":"Crossref","is-referenced-by-count":9,"title":["Oxidative damage in brains of mice treated with apomorphine and its oxidized derivative"],"prefix":"10.1016","volume":"992","author":[{"given":"Jos\u00e9 Cl\u00e1udio F.","family":"Moreira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felipe","family":"Dal-Pizzol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernanda","family":"Bonatto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evandro Gomes","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D\u00e9bora G.","family":"Flores","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaqueline N.","family":"Picada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Roesler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o Antonio P\u00eagas","family":"Henriques","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainres.2003.08.051_BIB1","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0076-6879(84)05016-3","article-title":"Catalase in vitro","volume":"105","author":"Aebi","year":"1984","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.brainres.2003.08.051_BIB2","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/9780470110539.ch5","article-title":"Assays for SOD","volume":"32","author":"Bannister","year":"1987","journal-title":"Methods Biochem. Anal."},{"key":"10.1016\/j.brainres.2003.08.051_BIB3","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/0891-5849(92)90182-G","article-title":"Biochemical and toxicological properties of the oxidation products of catecholamines","volume":"13","author":"Bindolli","year":"1992","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.brainres.2003.08.051_BIB4","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0006-8993(01)02081-9","article-title":"Potent, hydroxyl-radical-scavenging effect of apomorphine with iron and dopamine perfusion in rat striatum","volume":"896","author":"Chen","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2003.08.051_BIB5","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0028-3908(74)90107-5","article-title":"The effect of amantadine, l-dopa, (plus)-amphetamine and apomorphine on the acquisition of the conditioned avoidance response","volume":"13","author":"Davies","year":"1974","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.brainres.2003.08.051_BIB6","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2165\/00003088-200241040-00003","article-title":"Clinical pharmacokinetic and pharmacodynamic properties of drugs used in the treatment of Parkinson's disease","volume":"41","author":"Deleu","year":"2002","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.brainres.2003.08.051_BIB7","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/BF01245160","article-title":"Cholinergic and dopaminergic agents which inhibit a passive avoidance response attenuate the paradigm-specific increases in NCAM syalilation state","volume":"92","author":"Doyle","year":"1993","journal-title":"J. Neural Transm., Gen. Sect."},{"key":"10.1016\/j.brainres.2003.08.051_BIB8","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/BF02527720","article-title":"Nefiracetam (DM-9384) reverses apomorphine-induced amnesia of a passive avoidance response: delayed emergence of the memory retention effects","volume":"21","author":"Doyle","year":"1996","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.brainres.2003.08.051_BIB9","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0076-6879(90)86135-I","article-title":"Malondialdehyde determination as index of lipid peroxidation","volume":"186","author":"Draper","year":"1990","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.brainres.2003.08.051_BIB10","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0304-3940(99)00088-9","article-title":"Mechanisms of apomorphine cytoxicity towards rat glioma C6 cells: protection by bovine serum albumin and formation of apomorphine\u2013protein conjugates","volume":"263","author":"El-Bacha","year":"1999","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainres.2003.08.051_BIB11","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0006-2952(00)00524-4","article-title":"Toxic effects of apomorphine on rat cultured neurons and glial C6 cells, and protection with antioxidants","volume":"66","author":"El-Bach\u00e1","year":"2001","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.brainres.2003.08.051_BIB12","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/BF00426809","article-title":"Impairment by apomorphine of one-trial passive avoidance learning in mice: the opposing roles of the dopamine and noradrenaline systems","volume":"61","author":"Fernandez-Tome","year":"1979","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.brainres.2003.08.051_BIB13","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0006-8993(01)02125-4","article-title":"Dose-dependent protective effects of apomorphine against methamphetamine-induced nigrostriatal damage","volume":"898","author":"Fornai","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2003.08.051_BIB14","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0014-2999(96)00291-9","article-title":"Apomorphine is a highly potent free radical scavenger in rat brain mitochondrial fraction","volume":"308","author":"Gassen","year":"1996","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainres.2003.08.051_BIB15","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/mds.870130409","article-title":"Apomorphine enantiomers protect cultured pheochromocytoma (PC12) cells from oxidative stress induced by H2O2 and 6-hydroxydopamine","volume":"13","author":"Gassen","year":"1998","journal-title":"Mov. Disord."},{"key":"10.1016\/j.brainres.2003.08.051_BIB16","first-page":"633","article-title":"Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones","volume":"14","author":"Graham","year":"1978","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.brainres.2003.08.051_BIB17","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1046\/j.1471-4159.2001.t01-1-00227.x","article-title":"Effects of R- and S-apomorphine on MPTP-induced nigro-striatal dopamine neuronal loss","volume":"77","author":"Grunblatt","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2003.08.051_BIB18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1471-4159.2001.00397.x","article-title":"Gene expression analysis in N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice model of Parkinson's disease using cDNA microarray: effect of R-apomorphine","volume":"78","author":"Grunblatt","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2003.08.051_BIB19","series-title":"Free Radicals in Biology and Medicine","year":"1999"},{"key":"10.1016\/j.brainres.2003.08.051_BIB20","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0091-3057(88)90431-5","article-title":"Opposite effects induced by low and high doses of apomorphine on passive avoidance learning in mice","volume":"30","author":"Ichihara","year":"1988","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.brainres.2003.08.051_BIB21","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0027-5107(00)00073-7","article-title":"Dose finding in the Ames Salmonella assay","volume":"453","author":"Khromov-Borisov","year":"2000","journal-title":"Mutat. Res."},{"key":"10.1016\/j.brainres.2003.08.051_BIB22","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/0076-6879(90)86141-H","article-title":"Determination of carbonyl content in oxidatively modified proteins","volume":"186","author":"Levine","year":"1990","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.brainres.2003.08.051_BIB23","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0006-8993(95)00341-M","article-title":"Toxic effects of l-DOPA on mesencephalic cell cultures: protection with antioxidants","volume":"682","author":"Pardo","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2003.08.051_BIB24","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0014-2999(02)01553-4","article-title":"Differential neurobehavioral deficits induced by apomorphine and its oxidation product, 8-oxo-apomorphine-semiquinone, in rats","volume":"443","author":"Picada","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainres.2003.08.051_BIB25","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0920-9964(02)00426-7","article-title":"An oxidized form of apomorphine fails to induce stereotypy","volume":"63","author":"Picada","year":"2003","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.brainres.2003.08.051_BIB26","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0169-328X(03)00127-X","article-title":"DNA damage in brain cells of mice treated with an oxidized form of apomorphine","volume":"114","author":"Picada","year":"2003","journal-title":"Mol. Brain Res."},{"key":"10.1016\/j.brainres.2003.08.051_BIB27","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1383-5718(03)00132-3","article-title":"Differential mutagenic, antimutagenic and cytotoxic responses induced by apomorphine and its oxidation product, 8-oxo-apomorphine-semiquinone, in bacterial and yeast","volume":"539","author":"Picada","year":"2003","journal-title":"Mutat. Res."},{"key":"10.1016\/j.brainres.2003.08.051_BIB28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0304-4165(98)00036-1","article-title":"Metabolic activation of dopamine o-quinones to o-semiquinones by NADPH cytochrome P450 reductase may play an important role in oxidative stress and apoptotic effects","volume":"1381","author":"Segura-Aguillar","year":"1998","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.brainres.2003.08.051_BIB29","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.2174\/1381612003399581","article-title":"Dopamine agonists in the treatment of Parkinson's disease\u2014past, present and future","volume":"6","author":"Sit","year":"2000","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.brainres.2003.08.051_BIB30","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0920-9964(97)00005-4","article-title":"Oxidative reactions and schizophrenia","volume":"24","author":"Smythies","year":"1997","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.brainres.2003.08.051_BIB31","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/0014-5793(94)01056-0","article-title":"Intense oxidative DNA damage promoted by l-dopa and its metabolites. Implications for neurodegenerative disease","volume":"353","author":"Spence","year":"1994","journal-title":"FEBS Lett."},{"key":"10.1016\/j.brainres.2003.08.051_BIB32","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/S0891-5849(00)00180-5","article-title":"Is the endogenous peroxyl-radical scavenging capacity of plasma protective in systemic inflammatory disorders in humans?","volume":"28","author":"Tsai","year":"2000","journal-title":"Free Radic. Biol. Med."}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000689930303645X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000689930303645X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,22]],"date-time":"2019-02-22T16:28:39Z","timestamp":1550852919000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000689930303645X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,12]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2003,12]]}},"alternative-id":["S000689930303645X"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2003.08.051","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2003,12]]}}}